Diacerein attenuates inflammation in severe sepsis, and hence improves survival (104). Could be beneficial in reducing sepsis induced insulin resistance as an alternative to insulin therapy in severe sepsis cases where intensive insulin therapy is associated with adverse outcomes. Diacerein could be beneficial in managing diabetes patients infected with SARS-CoV-2. This evidence concerns the gene INS and Insulin resistance.